Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/8918500

Download in:

View as

General Info

PMID
8918500